EVENITY
Q2 2026 sales rose 38% to $714 million.
The numbers
EVENITY product sales$714 millionQ2 2026 · up 38% year over year · source ↗
What it is
Osteoporosis medicine for women with a high risk of bone fractures. It is one of Amgen's growth products in bone health.↗ source
Why it matters to the stock. EVENITY is the main growth offset to the Prolia decline inside Amgen's bone franchise.
News
No stories tagged to this project yet.